These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3226307)

  • 1. Inhibitors of chemotaxis.
    Maderazo EG; Woronick CL; Ward PA
    Methods Enzymol; 1988; 162():223-35. PubMed ID: 3226307
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of the regulation of complement-derived chemotactic factors in blunt trauma.
    Maderazo EG; Moore M; Woronick CL
    J Infect Dis; 1988 Feb; 157(2):364-7. PubMed ID: 3335811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protaminase activity of plasma. III. Role of conversion enzyme (kininase II) in protaminase activity of plasma].
    Blass J; Detruit H; Aime L; Fiancette JY; Gaillard M; Verriest C; Vicaigne MB; Weiss M
    Pathol Biol (Paris); 1988 Dec; 36(10):1192-8. PubMed ID: 2853323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotactic factors of bacterial origin.
    Marasco WA; Ward PA
    Methods Enzymol; 1988; 162():198-214. PubMed ID: 3067051
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotactic factors associated with leukocyte emigration in immune tissue injury: their separation, characterization, and functional specificity.
    Hayashi H; Honda M; Shimokawa Y; Hirashima M
    Int Rev Cytol; 1984; 89():179-250. PubMed ID: 6381365
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural inhibitors of leukotaxis.
    Ward PA
    Prog Clin Biol Res; 1977; 13():77-81. PubMed ID: 400762
    [No Abstract]   [Full Text] [Related]  

  • 7. Complement C4-derived monocyte-directed chemotaxis-inhibitory factor. A molecular mechanism to cause polymorphonuclear leukocyte-predominant infiltration in rheumatoid arthritis synovial cavities.
    Matsubara S; Yamamoto T; Tsuruta T; Takagi K; Kambara T
    Am J Pathol; 1991 May; 138(5):1279-91. PubMed ID: 2024711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of a neutrophil-derived inhibitor of fibroblast chemotaxis.
    Mensing H; Czarnetzki BM
    Arch Dermatol Res; 1986; 278(3):184-9. PubMed ID: 3015049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular mechanisms of leukocyte chemotaxis.
    Snyderman R; Goetzl EJ
    Science; 1981 Aug; 213(4510):830-7. PubMed ID: 6266014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of glycogen-induced guinea pig polymorphonuclear leukocytes to detect inhibitors of chemotaxis found in human serum.
    Judd RC; Rudbach JA
    Diagn Immunol; 1985; 3(1):1-6. PubMed ID: 3995877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mouse lymphocyte-derived chemotactic factor.
    Leonard EJ; Meltzer MS
    Cell Immunol; 1976 Oct; 26(2):200-10. PubMed ID: 788924
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapidly progressive periodontitis. Neutrophil chemotaxis inhibitory factors associated with the presence of Bacteroides gingivalis in crevicular fluid.
    Di Murro C; Nisini R; Cattabriga M; Simonetti-D'Arca A; Le Moli S; Paolantonio M; Sebastiani L; D'Amelio R
    J Periodontol; 1987 Dec; 58(12):868-72. PubMed ID: 3323463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotactic factor inactivator interaction with Gc-globulin (vitamin D-binding protein). A mechanism of modulating the chemotactic activity of C5a.
    Robbins RA; Hamel FG
    J Immunol; 1990 Mar; 144(6):2371-6. PubMed ID: 2313096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity.
    Schröder JM; Mrowietz U; Christophers E
    J Immunol; 1988 May; 140(10):3534-40. PubMed ID: 3283239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte accumulation in sparganosis: demonstration of eosinophil and neutrophil chemotactic factors from the plerocercoid of Spirometra erinacei in vivo and in vitro.
    Horii Y; Owhashi M; Ishii A; Bandou K; Usui M
    Am J Trop Med Hyg; 1984 Jan; 33(1):138-43. PubMed ID: 6364853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxypeptidase-type kininase of human kidney and urine.
    Marinkovic DV; Ward PE; Erdos EG; Mills IH
    Proc Soc Exp Biol Med; 1980 Oct; 165(1):6-12. PubMed ID: 7422678
    [No Abstract]   [Full Text] [Related]  

  • 17. [The isolation and partial characterization of neutrophil chemotactic factor from an oral bacterium, Streptococcus sanguis (author's transl)].
    Miyake Y
    Hiroshima Daigaku Shigaku Zasshi; 1981; 13(1):1-8. PubMed ID: 6945350
    [No Abstract]   [Full Text] [Related]  

  • 18. A chemotactic inhibitory factor in the minimal change nephrotic syndrome.
    Lin CY; Su SN
    Int J Pediatr Nephrol; 1986; 7(4):191-6. PubMed ID: 3818178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of an eosinophil chemotactic lymphokine as a natural mediator for eosinophil chemotaxis from concanavalin A-induced skin reaction sites in guinea-pigs.
    Hirashima M; Tashiro K; Sakata K; Hirashima M
    Clin Exp Immunol; 1984 Jul; 57(1):211-9. PubMed ID: 6378462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibitors of leukocyte chemotaxis in Crohn's disease and ulcerative colitis.
    Rhodes JM; Potter BJ; Brown DJ; Jewell DP
    Gastroenterology; 1982 Jun; 82(6):1327-34. PubMed ID: 6978274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.